1. Home
  2. AREC vs SPRO Comparison

AREC vs SPRO Comparison

Compare AREC & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREC
  • SPRO
  • Stock Information
  • Founded
  • AREC 2013
  • SPRO 2013
  • Country
  • AREC United States
  • SPRO United States
  • Employees
  • AREC 26
  • SPRO N/A
  • Industry
  • AREC Coal Mining
  • SPRO Biotechnology: Pharmaceutical Preparations
  • Sector
  • AREC Energy
  • SPRO Health Care
  • Exchange
  • AREC Nasdaq
  • SPRO Nasdaq
  • Market Cap
  • AREC 37.9M
  • SPRO 45.7M
  • IPO Year
  • AREC 2019
  • SPRO 2017
  • Fundamental
  • Price
  • AREC $0.50
  • SPRO $0.84
  • Analyst Decision
  • AREC Strong Buy
  • SPRO Buy
  • Analyst Count
  • AREC 3
  • SPRO 4
  • Target Price
  • AREC $4.33
  • SPRO $5.00
  • AVG Volume (30 Days)
  • AREC 1.4M
  • SPRO 118.7K
  • Earning Date
  • AREC 05-20-2025
  • SPRO 03-27-2025
  • Dividend Yield
  • AREC N/A
  • SPRO N/A
  • EPS Growth
  • AREC N/A
  • SPRO N/A
  • EPS
  • AREC N/A
  • SPRO N/A
  • Revenue
  • AREC $399,962.00
  • SPRO $47,977,000.00
  • Revenue This Year
  • AREC N/A
  • SPRO N/A
  • Revenue Next Year
  • AREC $3,208.62
  • SPRO N/A
  • P/E Ratio
  • AREC N/A
  • SPRO N/A
  • Revenue Growth
  • AREC N/A
  • SPRO N/A
  • 52 Week Low
  • AREC $0.41
  • SPRO $0.73
  • 52 Week High
  • AREC $1.59
  • SPRO $1.81
  • Technical
  • Relative Strength Index (RSI)
  • AREC 46.96
  • SPRO 54.74
  • Support Level
  • AREC $0.51
  • SPRO $0.75
  • Resistance Level
  • AREC $0.63
  • SPRO $0.80
  • Average True Range (ATR)
  • AREC 0.07
  • SPRO 0.04
  • MACD
  • AREC 0.01
  • SPRO 0.01
  • Stochastic Oscillator
  • AREC 44.91
  • SPRO 46.08

About AREC American Resources Corporation

American Resources Corp is a next-generation, environmentally, and socially responsible supplier of high-quality raw materials to the new infrastructure market. The firm is focused on the extraction and processing of metallurgical carbon, an essential ingredient used in steelmaking, critical and rare earth minerals for the electrification market, and reprocessed metal to be recycled. The firm has a growing portfolio of operations located in the Central Appalachian basin of eastern Kentucky and southern West Virginia where premium quality metallurgical carbon and rare earth mineral deposits are concentrated. Its business model provides a significant opportunity to scale its portfolio of assets to meet the growing global infrastructure and electrification markets.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: